[1] 中华医学会内分泌学分会. 嗜铬细胞瘤和副神经节瘤诊断治疗专家共识(2020版)[J]. 中华内分泌代谢杂志,2020,36:737-750. [2] 王莉娟,张国霞,刘海龙,等.姜黄素抗肿瘤作用及其作用机制研究进展[J].甘肃中医药大学学报,2022,39:78-82. [3] 涂启敏,黄宏灵.PI3K/AKT/mTOR在姜黄素抑制食管癌细胞增殖中的作用[J].解剖学研究,2018,40:174-177. [4] Fu H, Wang C, Yang D, et al. Curcumin regulates proliferation, autophagy, and apoptosis in gastric cancer cells by affecting PI3K and p53 signaling[J]. J Cell Physiol, 2018, 233:4634-4642. [5] 刘少琼,杨芳,禹正杨,等.姜黄素调控Notch1信号通路诱导结肠癌SW480细胞株凋亡[J].湖南中医药大学学报,2015,35:13-16. [6] Tsai, Jong-Rung, et al. Curcumin inhibits non-small cell lung cancer cells metastasis through the adiponectin/NF-κb/MMPs sgnaling pathway[J. PLoS One vol, 2015,12:e0144462. doi:10.1371/journal.pone.0144462. [7] 陈海滔.姜黄素调控NKD2-Wnt-CXCR4通路抑制结肠癌细胞的侵润转移[D].杭州:浙江中医药大学,2017:10-13. [8] 曹聪,黄桂柳,黄赞松,等.姜黄素对肝癌耐药细胞HepG2/ADM的增殖和阿霉素耐药性的影响[J].广西医学,2020,42:976-980. [9] 徐露,张鑫杰,张闰哲,等.姜黄素逆转结肠癌HCT-116/5FU细胞耐药作用机制研究[J].浙江中西医结合杂志,2020,30:454-457+524. [10] Zheng A, Li H, Wang X, et al. Anticancer effect of a curcumin derivative B63: ROS production and mitochondrial dysfunction[J]. Curr Cancer Drug Tar, 2014, 14. doi: 10.2174/1568009613666131126115444. [11] Vadhan-Raj S, Weber D, Wang M, et al. Curcumin downregulates NF-κB and related genes in patients with multiple myeloma: results of a phase Ⅰ/Ⅱ study[J]. Blood, 2024, 110.doi: 10.1182/blood.v110.11.1177.1177. [12] Bayet-Robert M, Kwiatkowski F, Leheurteur M, et al. Phase Ⅰ dose escalation trial of docetaxel plus curcumin in patients with advanced and metastatic breast cancer[J]. Cancer Biol Ther, 2010, 9.doi: 10.4161/cbt.9.1.10392. [13] Dhillon N, Wolff R, Abbruzzese J, et al. Phase Ⅱ clinical trial of curcumin in patients with advanced pancreatic cancer[J].J Clin Oncol,2024,24. doi: 10.1200/jco.2006.24.18_suppl.14151. [14] 佟凤芝,曾常茜,王建华.姜黄素在神经元退行性疾病中的应用研究进展[J].中国中医药科技,2016,23:628-629+631. |